You are currently logged into
Hep Directory - My Account or Log Out

Home
Basics
News
- News
- Newsfeed
- Science News
- Features
- Conferences
- Hep Stories
- Hep Slideshows
- Hep TV
- By Author
- RSS Links
Hot Topics
Magazine
Blogs
Community
- Community
- Hep Stories
- Hep Forums
- Polls
- Surveys
- Ask Hep
- Services Directory
- Calendar
- Bookstore
About Us
- About Us
- About Us
- Masthead
- Awards
- Advertise
- Contact Us
Facebook
Twitter

© 2022 Smart + Strong.
All Rights Reserved.
Terms of use and
Your privacy.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.

Twitter

Facebook

Tumblr

#bladder cancer

FDA Reconsiders Accelerated Approvals of Immunotherapy Drugs

An advisory panel reviewed follow-up data on checkpoint inhibitors, voting to maintain four approvals and rescind two.

Those Treated With Newer Hep C Drugs Have Lower Non-Liver Cancer Rates

The link between the older interferon treatment and these cancers may be related to the drug’s low hep C cure rate.

Stay Logged In?

You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.

You Have Been Logged Out

Click here to log back in.

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.